Microneedle ocular patch : fabrication, characterization, and ex-vivo evaluation using pilocarpine as model drug
Context: Enhacing the ocular bioavailability of drugs after their topical application is a challenge.Objective: The objective of the study was to design, fabricate, and investigate the effectiveness of microneedle ocular patch (MOP) in delivering the model drug, pilocarpine HCl across the corneal membrane.Methods: MOP mimicked commercially available contact lens design elements having a diameter of 14.20 mm and a sagittal height of 3.85 mm with a convex curvature. The base of this patch contained an array of 25 pyramid-shaped microneedles measuring 521 ± 10 µm in length. Pilocarpine loaded MOP was prepared by micromolding technique using dissolvable polyvinyl alcohol and polyvinyl pyrrolidone matrix. MOP was characterized for physical and mechanical properties using a stereomicroscope, scanning electron microscope, and texture analyzer.Results: Histological examination after MOP application on excised human cornea showed penetration of microneedles with a required insertional force of 1.04 ± 0.17 N. Flux of pilocarpine across excised cornea was significantly (p < 0.05) greater after application of MOP (704 ± 149 µg/cm2/h) compared with solution formulation (188 ± 24 µg/cm2/h). Ex-vivo pilocarpine permeation study in porcine eye globe revealed significantly (p < 0.05) greater availability in aqueous humor within 30 min of application of MOP (249 ± 85 µg/ml) compared with solution formulation (46 ± 9 µg/ml).Conclusion: MOP can be developed as a potential ophthalmic drug delivery system.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Drug development and industrial pharmacy - 46(2020), 7 vom: 14. Juli, Seite 1114-1122 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Roy, Girdhari [VerfasserIn] |
---|
Links: |
---|
Themen: |
01MI4Q9DI3 |
---|
Anmerkungen: |
Date Completed 16.03.2021 Date Revised 16.03.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/03639045.2020.1776317 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310493870 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310493870 | ||
003 | DE-627 | ||
005 | 20231225140215.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/03639045.2020.1776317 |2 doi | |
028 | 5 | 2 | |a pubmed24n1034.xml |
035 | |a (DE-627)NLM310493870 | ||
035 | |a (NLM)32468863 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Roy, Girdhari |e verfasserin |4 aut | |
245 | 1 | 0 | |a Microneedle ocular patch |b fabrication, characterization, and ex-vivo evaluation using pilocarpine as model drug |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.03.2021 | ||
500 | |a Date Revised 16.03.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Context: Enhacing the ocular bioavailability of drugs after their topical application is a challenge.Objective: The objective of the study was to design, fabricate, and investigate the effectiveness of microneedle ocular patch (MOP) in delivering the model drug, pilocarpine HCl across the corneal membrane.Methods: MOP mimicked commercially available contact lens design elements having a diameter of 14.20 mm and a sagittal height of 3.85 mm with a convex curvature. The base of this patch contained an array of 25 pyramid-shaped microneedles measuring 521 ± 10 µm in length. Pilocarpine loaded MOP was prepared by micromolding technique using dissolvable polyvinyl alcohol and polyvinyl pyrrolidone matrix. MOP was characterized for physical and mechanical properties using a stereomicroscope, scanning electron microscope, and texture analyzer.Results: Histological examination after MOP application on excised human cornea showed penetration of microneedles with a required insertional force of 1.04 ± 0.17 N. Flux of pilocarpine across excised cornea was significantly (p < 0.05) greater after application of MOP (704 ± 149 µg/cm2/h) compared with solution formulation (188 ± 24 µg/cm2/h). Ex-vivo pilocarpine permeation study in porcine eye globe revealed significantly (p < 0.05) greater availability in aqueous humor within 30 min of application of MOP (249 ± 85 µg/ml) compared with solution formulation (46 ± 9 µg/ml).Conclusion: MOP can be developed as a potential ophthalmic drug delivery system | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Microneedle ocular patch | |
650 | 4 | |a corneal permeation | |
650 | 4 | |a flux | |
650 | 4 | |a micromolding | |
650 | 4 | |a pilocarpine | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
650 | 7 | |a Pilocarpine |2 NLM | |
650 | 7 | |a 01MI4Q9DI3 |2 NLM | |
650 | 7 | |a Povidone |2 NLM | |
650 | 7 | |a FZ989GH94E |2 NLM | |
700 | 1 | |a Galigama, Rohini Devi |e verfasserin |4 aut | |
700 | 1 | |a Thorat, Veda Suresh |e verfasserin |4 aut | |
700 | 1 | |a Garg, Prashant |e verfasserin |4 aut | |
700 | 1 | |a Venuganti, Venkata Vamsi Krishna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug development and industrial pharmacy |d 1994 |g 46(2020), 7 vom: 14. Juli, Seite 1114-1122 |w (DE-627)NLM077783093 |x 1520-5762 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2020 |g number:7 |g day:14 |g month:07 |g pages:1114-1122 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/03639045.2020.1776317 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2020 |e 7 |b 14 |c 07 |h 1114-1122 |